Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
E A Fagan and A L Eddleston
Gut 1987; 28: 113-116. doi:10.1136/gut.28.2.113
[PDF]
[Request Permissions]
Lysis of primary hepatic tumours by lymphokine activated killer cells.
K H Hsieh, S Y Shu, C S Lee, C T Chu, C S Yang, and K J Chang
Gut 1987; 28: 117-124. doi:10.1136/gut.28.2.117
[Abstract]
[PDF]
[Request Permissions]
Porphyrin metabolism and haem biosynthesis in Gilbert's syndrome.
K E McColl, G G Thompson, E el Omar, M R Moore, and A Goldberg
Gut 1987; 28: 125-130. doi:10.1136/gut.28.2.125
[Abstract]
[PDF]
[Request Permissions]
Intragastric bile acid concentrations are unrelated to symptoms of flatulent dyspepsia in patients with and without gallbladder disease and postcholecystectomy.
R G Watson and A H Love
Gut 1987; 28: 131-136. doi:10.1136/gut.28.2.131
[Abstract]
[PDF]
[Request Permissions]
Gall bladder emptying in normal subjects--a data base for clinical cholescintigraphy.
C R Mackie, J N Baxter, J S Grime, G Hulks, and A Cuschieri
Gut 1987; 28: 137-141. doi:10.1136/gut.28.2.137
[Abstract]
[PDF]
[Request Permissions]
Endoscopic sphincterotomy and surgical approaches in the treatment of the 'sump syndrome'.
U A Marbet, G A Stalder, H Faust, F Harder, and K Gyr
Gut 1987; 28: 142-145. doi:10.1136/gut.28.2.142
[Abstract]
[PDF]
[Request Permissions]
Is there a relationship between symptoms of the irritable bowel syndrome and objective measurements of large bowel function? A longitudinal study.
G J Oettlé and K W Heaton
Gut 1987; 28: 146-149. doi:10.1136/gut.28.2.146
[Abstract]
[PDF]
[Request Permissions]
Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight.
A Kumar, N Kumar, J C Vij, S K Sarin, and B S Anand
Gut 1987; 28: 150-155. doi:10.1136/gut.28.2.150
[Abstract]
[PDF]
[Request Permissions]
Irritable bowel-type symptoms in spontaneous and induced constipation.
S N Marcus and K W Heaton
Gut 1987; 28: 156-159. doi:10.1136/gut.28.2.156
[Abstract]
[PDF]
[Request Permissions]
Life events, psychiatric illness and the irritable bowel syndrome.
M J Ford, P M Miller, J Eastwood, and M A Eastwood
Gut 1987; 28: 160-165. doi:10.1136/gut.28.2.160
[Abstract]
[PDF]
[Request Permissions]
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers.
A P Savage, T E Adrian, G Carolan, V K Chatterjee, and S R Bloom
Gut 1987; 28: 166-170. doi:10.1136/gut.28.2.166
[Abstract]
[PDF]
[Request Permissions]
Effects of an elemental diet, inert bulk and different types of dietary fibre on the response of the intestinal epithelium to refeeding in the rat and relationship to plasma gastrin, enteroglucagon, and PYY concentrations.
R A Goodlad, W Lenton, M A Ghatei, T E Adrian, S R Bloom, and N A Wright
Gut 1987; 28: 171-180. doi:10.1136/gut.28.2.171
[Abstract]
[PDF]
[Request Permissions]
Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils.
O H Nielsen, I Ahnfelt-Rønne, and J Elmgreen
Gut 1987; 28: 181-185. doi:10.1136/gut.28.2.181
[Abstract]
[PDF]
[Request Permissions]
Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis.
G D Barr, M J Hudson, J D Priddle, and D P Jewell
Gut 1987; 28: 186-189. doi:10.1136/gut.28.2.186
[Abstract]
[PDF]
[Request Permissions]
Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
Y Miyachi, A Yoshioka, S Imamura, and Y Niwa
Gut 1987; 28: 190-195. doi:10.1136/gut.28.2.190
[Abstract]
[PDF]
[Request Permissions]
Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract.
B Myers, D N Evans, J Rhodes, B K Evans, B R Hughes, M G Lee, A Richens, and D Richards
Gut 1987; 28: 196-200. doi:10.1136/gut.28.2.196
[Abstract]
[PDF]
[Request Permissions]
Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
S J Konturek, T Radecki, I Piastucki, T Brzozowski, and D Drozdowicz
Gut 1987; 28: 201-205. doi:10.1136/gut.28.2.201
[Abstract]
[PDF]
[Request Permissions]
Effect of intragastric pH on antral gastrin and somatostatin release in anaesthetised, atropinised duodenal ulcer patients and controls.
S L Jensen, J J Holst, L A Christiansen, M H Shokouh-Amiri, M Lorentsen, H Beck, and H E Jensen
Gut 1987; 28: 206-209. doi:10.1136/gut.28.2.206
[Abstract]
[PDF]
[Request Permissions]
Clinical markers of slow healing and relapsing gastric ulcer.
G Battaglia, F Di Mario, A Piccoli, F Vianello, F Farinati, and R Naccarato
Gut 1987; 28: 210-215. doi:10.1136/gut.28.2.210
[Abstract]
[PDF]
[Request Permissions]
Urinary N-nitrosoproline excretion: a further evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions.
C N Hall, J S Kirkham, and T C Northfield
Gut 1987; 28: 216-220. doi:10.1136/gut.28.2.216
[Abstract]
[PDF]
[Request Permissions]
Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.
M R Lucey, M L Clark, J Lowndes, and A M Dawson
Gut 1987; 28: 221-225. doi:10.1136/gut.28.2.221
[Abstract]
[PDF]
[Request Permissions]
Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease.
C Manniche, A Malchow-Møller, J R Andersen, C Pedersen, T M Hansen, P Jess, L Helleberg, S N Rasmussen, U Tage-Jensen, and S E Nielsen
Gut 1987; 28: 226-229. doi:10.1136/gut.28.2.226
[Abstract]
[PDF]
[Request Permissions]